It has been posited that irisin levels could be elevated in obese patients as a compensatory mechanism to progressive fat accumulation [18], and also that this hormone could partly mediate the improvement of glucose metabolism observed after weight reduction in obese patients with metabolic syndrome [19]. Here, FNDC5 is linked to metabolic syndrome.